Literature DB >> 18485534

The heat shock response modulates transthyretin deposition in the peripheral and autonomic nervous systems.

Sofia Duque Santos1, Rui Fernandes, Maria João Saraiva.   

Abstract

Familial amyloidotic polyneuropathy (FAP) is a neurodegenerative disease that selectively affects the peripheral nervous system. The putative cause of this life threatening pathology is tissue deposition of mutant transthyretin (TTR), initially as non-fibrillar deposits and later as fibrillar material. The mouse models currently available do not recapitulate the human whole features, since the peripheral nervous tissue is spared. We have characterized a new mouse model expressing the human transthyretin V30M in a heat shock transcription factor 1 (Hsf1) null background. The lack of HSF1 expression leads to an extensive and earlier non-fibrillar TTR, evolving into fibrillar material in distinct organs including the peripheral nervous system. Furthermore, inflammatory stress and a reduction in unmyelinated nerve fibers were observed, as in human patients. These results indicate that HSF1 regulated genes are involved in FAP, modulating TTR tissue deposition. The novel mouse model is of the utmost importance in testing new therapeutic strategies and in addressing the influence of the stress response in misfolding diseases.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 18485534     DOI: 10.1016/j.neurobiolaging.2008.04.001

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  20 in total

1.  Why are some amyloidoses systemic? Does hepatic "chaperoning at a distance" prevent cardiac deposition in a transgenic model of human senile systemic (transthyretin) amyloidosis?

Authors:  Joel N Buxbaum; Clement Tagoe; Gloria Gallo; John R Walker; Sunil Kurian; Daniel R Salomon
Journal:  FASEB J       Date:  2012-02-23       Impact factor: 5.191

2.  The systemic amyloid precursor transthyretin (TTR) behaves as a neuronal stress protein regulated by HSF1 in SH-SY5Y human neuroblastoma cells and APP23 Alzheimer's disease model mice.

Authors:  Xin Wang; Francesca Cattaneo; Lisa Ryno; John Hulleman; Natàlia Reixach; Joel N Buxbaum
Journal:  J Neurosci       Date:  2014-05-21       Impact factor: 6.167

3.  αB-crystallin (HspB5) in familial amyloidotic polyneuropathy.

Authors:  Joana Magalhães; Sofia Duque Santos; Maria João Saraiva
Journal:  Int J Exp Pathol       Date:  2010-08-27       Impact factor: 1.925

Review 4.  Animal models of human amyloidoses: are transgenic mice worth the time and trouble?

Authors:  Joel N Buxbaum
Journal:  FEBS Lett       Date:  2009-07-20       Impact factor: 4.124

5.  Molecular tweezers for lysine and arginine - powerful inhibitors of pathologic protein aggregation.

Authors:  Thomas Schrader; Gal Bitan; Frank-Gerrit Klärner
Journal:  Chem Commun (Camb)       Date:  2016-08-22       Impact factor: 6.222

6.  Synergy of combined doxycycline/TUDCA treatment in lowering Transthyretin deposition and associated biomarkers: studies in FAP mouse models.

Authors:  Isabel Cardoso; Diana Martins; Tania Ribeiro; Giampaolo Merlini; Maria João Saraiva
Journal:  J Transl Med       Date:  2010-07-30       Impact factor: 5.531

7.  Epigallocatechin-3-gallate as a potential therapeutic drug for TTR-related amyloidosis: "in vivo" evidence from FAP mice models.

Authors:  Nelson Ferreira; Maria João Saraiva; Maria Rosário Almeida
Journal:  PLoS One       Date:  2012-01-10       Impact factor: 3.240

8.  The Expression of Chemokines Is Downregulated in a Pre-Clinical Model of TTR V30M Amyloidosis.

Authors:  João Moreira; Susete Costelha; Margarida Saraiva; Maria João Saraiva
Journal:  Front Immunol       Date:  2021-05-19       Impact factor: 7.561

9.  The proteome response to amyloid protein expression in vivo.

Authors:  Ricardo A Gomes; Catarina Franco; Gonçalo Da Costa; Sébastien Planchon; Jenny Renaut; Raquel M Ribeiro; Francisco Pinto; Marta Sousa Silva; Ana Varela Coelho; Ana Ponces Freire; Carlos Cordeiro
Journal:  PLoS One       Date:  2012-11-21       Impact factor: 3.240

10.  Induced pluripotent stem cell modeling of multisystemic, hereditary transthyretin amyloidosis.

Authors:  Amy Leung; Shirley K Nah; Whitney Reid; Atsushi Ebata; Clarissa M Koch; Stefano Monti; Joseph C Genereux; R Luke Wiseman; Benjamin Wolozin; Lawreen H Connors; John L Berk; David C Seldin; Gustavo Mostoslavsky; Darrell N Kotton; George J Murphy
Journal:  Stem Cell Reports       Date:  2013-10-31       Impact factor: 7.765

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.